Abstract:To discuss the clinical features of glucose metabolism in PCOS patients in northern Chinese Han women and to analyze their reproductive endocrinology and glucose and lipid metabolism. A prospective Cohort study. 1212 consecutive PCOS patients aged 23-38 registered at Peking University Third Hospital Reproductive Medical Center from April 2009 to August 2012 were recruited in this study. All patients met the PCOS diagnosis standard set by 2003 Rotterdam Conference. Patients’ heights, weights, pelvic examination, transvaginal B-ultrasound examination were taken; antral follicles counts, serum sex hormone level, blood lipid parameters, OGTT and insulin release test were measured; and body mass index, HOMA-IR, HOMA-β, Glucose, Insulin Area Under Curve were calculated. PCOS patients were divided into NGT group, IFG group, IGT group, CGI group, and T2DM group, according to their glucose levels. The glucose metabolism indexes, lipid metabolism indexes, and androgen levels among the groups were also compared. In the 1212 PCOS patients, 35.6% had Glucose Tolerance abnormalities, 5.9% had T2DM. 10.3% had IFG, 18.5% had IGT, and 6.5% had a mixture of IFG and IGT. When the glucose metabolism abnormality worsens, there was an increase of the body mass index and a decrease of the manifestation of PCO, androgen level, and the LH/FSH; Among the groups of IGT, CGI, and T2DM, there was no significant difference of androgen levels and LH/FSH. With the aggravation of glucose metabolism, the glucose level and insulin level gradually increase. The secretion of insulin 2 h after glucose load is significantly higher than 1 h after glucose load in IGT, CGI, and T2DM groups, but in IFG group the increase of insulin is insignificant. In all groups, HOMA-IR increases and HOMA-β decreases. There were no differences of the INSAUC and GLUAUC between IFG group and NGT group. When the glucose metabolism abnormality intensifies, TCHO, TG, and LDL levels of all groups increase while HDL gradually decreases, but in IFG group the changes were not significant. PCOS can be divided into two clinical subtypes based on glucose metabolism: one manifests as subfertility, and the other manifests as abnormal glucose and lipid metabolism. This division will greatly contribute to clinical observation, treatment, and follow-up.

Expression of miR-93 and Glucose Transporter Type 4 Mediated by Ginkgolide in Peripheral Blood with Polycystic Ovary Syndrome and Its Clinical Significance

Aberrant elevation of growth differentiation factor 8 impairs granulosa-lutein cell glucose metabolism via upregulating SERPINE1 expression in polycystic ovary syndrome patient

Decreased Serum Levels of the Insulin Resistance-Related microRNA miR-320a in Patients with Polycystic Ovary Syndrome

MicroRNA-93 promotes ovarian granulosa cells proliferation through targeting CDKN1A in polycystic ovarian syndrome

Differential expression of microRNA in the serum of patients with polycystic ovary syndrome with insulin resistance

MiRNAs Regulating Insulin Sensitivity Are Dysregulated in Polycystic Ovary Syndrome (PCOS) Ovaries and Are Associated With Markers of Inflammation and Insulin Sensitivity

Association of Serum Thyroid Hormone Levels with Androgen and Metabolic Parameters in Chinese Women with Polycystic Ovary Syndrome: A Retrospective Cross-Sectional Study

Expression of PPARγmRNA in Granulosa Cells and Its Correlation with Clinical Characteristics of Polycystic Ovary Syndrome

ANGPTL4 Expression in Ovarian Granulosa Cells Is Associated With Polycystic Ovary Syndrome

Aberrant miRNA-mRNA regulatory network in polycystic ovary syndrome is associated with markers of insulin sensitivity and inflammation

Serum microRNAs in young women with polycystic ovary syndrome and their association with glucose metabolism

Functional Characterization of MicroRNA-27a-3p Expression in Human Polycystic Ovary Syndrome

Glucose and Lipid Metabolism Status in Northern Chinese Han PCOS Patients: a Cohort Study

MiRNA-335-5p Negatively Regulates Granulosa Cell Proliferation Via SGK3 in PCOS

Expression and Regulation of CD36 Mrna in Granulosa Cells and Its Relation with Clinical Characteristics of Polycystic Ovary Syndrome

Circulating Micrornas in Patients with Polycystic Ovary Syndrome.

Follicular fluid-derived extracellular vesicles miR-34a-5p regulates granulosa cell glycolysis in polycystic ovary syndrome by targeting LDHA

Elevated Circulating Levels of Irisin and the Effect of Metformin Treatment in Women with Polycystic Ovary Syndrome.

Downregulation of serum long noncoding RNA GAS5 may contribute to insulin resistance in PCOS patients

Hyperandrogenic Milieu Dysregulates the Expression of Insulin Signaling Factors and Glucose Transporters in the Endometrium of Patients With Polycystic Ovary Syndrome

Several critical genes and microRNAs associated with the development of polycystic ovary syndrome